News

Timbercreek Financial amended its existing revolving credit facilities to extend the term of the facility for an additional year to December 18, 2021.

Urovant Sciences has entered into a $300 million term loan facility with Sumitomo Dainippon Pharma, a global Japanese pharmaceutical company.

The ABF Journal offices will be closed Wednesday, January 1 in observance of the new year.

Melinta Therapeutics entered into a restructuring support agreement with the lenders under its senior credit facility, Deerfield Private Design Fund III, L.P. and Deerfield Private Design Fund IV.

Mary E. “Mimi” Thigpen has been appointed to Opus Bank’s board of directors, effective December 27, 2019, and appointed a member of each of the Audit Committee and Risk Oversight Committee.

The Wall Street Journal reported that Toms Shoes, the company that donates a pair of shoes to a poor child for each pair it sells, is handing ownership to creditors in an out-of-court recapitalization.

Curaleaf Holdings has received commitments from a syndicate of lenders for a $275 million senior secured term loan facility bearing interest at a rate of 13.0% per annum, payable quarterly in arrears, with a maturity 48 months from closing.

Diamond S Shipping closed a five-year $525 million credit facility, composed of a $375 million term loan and a $150 million revolving credit facility.

Bruker has closed a new five-year revolving credit facility with expanded capacity to borrow up to $600 million, and a new seven-year term loan in the aggregate principal amount of $300 million, together with cross-currency and interest rate swap arrangements.

TherapeuticsMD and TPG Sixth Street Partners have amended the terms of the company’s existing term loan financing facility to revise the draw trigger for one of the two $50 million delayed draw loan tranches thereunder.